Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Saltarella

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Cells|January 16, 2020
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple MyelomaIlaria Saltarella, Vanessa Desantis, Assunta Melaccio, et al.
Journal of Cellular Physiology|July 1, 2024
RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cellsMariangela Centrone, Ilaria Saltarella, Mariagrazia D'Agostino, et al.
Annals of Hematology|March 29, 2018
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myelomaVanessa Desantis, Maria Antonia Frassanito, Roberto Tamma, et al.
Experimental Neurology|January 31, 2023
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional studyVeria Vacchiano, Raffaella Brugnoni, Carmen Campanale, et al.
Oncoimmunology|December 15, 2018
Bone marrow endothelial cells sustain a tumor-specific CD8<sup>+</sup> T cell subset with suppressive function in myeloma patientsPatrizia Leone, Giuseppe Di Lernia, Antonio Giovanni Solimando, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myelomaIlaria Saltarella, Alexander Link, Aurelia Lamanuzzi, et al.
Surgery|June 3, 2020
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?Roberto Ria, Francesco Prete, Assunta Melaccio, et al.
Cancers|August 7, 2021
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma DiseaseVanessa Desantis, Antonio Giovanni Solimando, Ilaria Saltarella, et al.
Oncotarget|May 15, 2018
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myelomaAurelia Lamanuzzi, Ilaria Saltarella, Vanessa Desantis, et al.
Haematologica|April 6, 2019
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myelomaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Cells|January 16, 2020
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple MyelomaIlaria Saltarella, Vanessa Desantis, Assunta Melaccio, et al.
Journal of Cellular Physiology|July 1, 2024
RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cellsMariangela Centrone, Ilaria Saltarella, Mariagrazia D'Agostino, et al.
Annals of Hematology|March 29, 2018
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myelomaVanessa Desantis, Maria Antonia Frassanito, Roberto Tamma, et al.
Experimental Neurology|January 31, 2023
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional studyVeria Vacchiano, Raffaella Brugnoni, Carmen Campanale, et al.
Oncoimmunology|December 15, 2018
Bone marrow endothelial cells sustain a tumor-specific CD8<sup>+</sup> T cell subset with suppressive function in myeloma patientsPatrizia Leone, Giuseppe Di Lernia, Antonio Giovanni Solimando, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myelomaIlaria Saltarella, Alexander Link, Aurelia Lamanuzzi, et al.
Surgery|June 3, 2020
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?Roberto Ria, Francesco Prete, Assunta Melaccio, et al.
Cancers|August 7, 2021
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma DiseaseVanessa Desantis, Antonio Giovanni Solimando, Ilaria Saltarella, et al.
Oncotarget|May 15, 2018
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myelomaAurelia Lamanuzzi, Ilaria Saltarella, Vanessa Desantis, et al.
Haematologica|April 6, 2019
Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myelomaLaura Mazzera, Manuela Abeltino, Guerino Lombardi, et al.
Pageof 5